These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 22222345)

  • 1. A pilot study assessing the frequency and complexity of methadone tapers for opioid abstinence syndrome in children discharged to home.
    Johnson PN; Harrison DL; Castro CH; Miller JL
    Res Social Adm Pharm; 2012; 8(5):455-63. PubMed ID: 22222345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. External validation of the medication taper complexity score for methadone tapers in children with opioid abstinence syndrome.
    Johnson PN; Miller JL; Hagemann TM; Castro C; Harrison D
    Ann Pharmacother; 2014 Feb; 48(2):187-95. PubMed ID: 24259650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between intrapartum fetal heart rate patterns and neonatal abstinence syndrome in methadone exposed neonates.
    Leeman LM; Brown SA; Albright B; Skipper B; Hsi A; Rayburn WF
    J Matern Fetal Neonatal Med; 2011 Jul; 24(7):955-9. PubMed ID: 21142769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting length of treatment for neonatal abstinence syndrome in methadone-exposed neonates.
    Seligman NS; Salva N; Hayes EJ; Dysart KC; Pequignot EC; Baxter JK
    Am J Obstet Gynecol; 2008 Oct; 199(4):396.e1-7. PubMed ID: 18928986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of infant feeding method on neonatal abstinence scores of methadone-exposed infants.
    McQueen KA; Murphy-Oikonen J; Gerlach K; Montelpare W
    Adv Neonatal Care; 2011 Aug; 11(4):282-90. PubMed ID: 22123351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioid maintenance treatment during pregnancy: occurrence and severity of neonatal abstinence syndrome. A national prospective study.
    Bakstad B; Sarfi M; Welle-Strand GK; Ravndal E
    Eur Addict Res; 2009; 15(3):128-34. PubMed ID: 19332991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of a clinical pathway with methadone treatment protocol for treatment of neonatal abstinence syndrome following in utero drug exposure to substances of abuse*.
    Bhatt-Mehta V; Ng CM; Schumacher RE
    Pediatr Crit Care Med; 2014 Feb; 15(2):162-9. PubMed ID: 24141658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrospective chart review comparing morphine and methadone in neonates treated for neonatal abstinence syndrome.
    Young ME; Hager SJ; Spurlock D
    Am J Health Syst Pharm; 2015 Dec; 72(23 Suppl 3):S162-7. PubMed ID: 26582303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose methadone maintenance in pregnancy: maternal and neonatal outcomes.
    McCarthy JJ; Leamon MH; Parr MS; Anania B
    Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 1):606-10. PubMed ID: 16150249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between maternal methadone dose at delivery and neonatal abstinence syndrome.
    Seligman NS; Almario CV; Hayes EJ; Dysart KC; Berghella V; Baxter JK
    J Pediatr; 2010 Sep; 157(3):428-33, 433.e1. PubMed ID: 20472252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal methadone use in pregnancy: factors associated with the development of neonatal abstinence syndrome and implications for healthcare resources.
    Dryden C; Young D; Hepburn M; Mactier H
    BJOG; 2009 Apr; 116(5):665-71. PubMed ID: 19220239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome.
    Jones HE; Johnson RE; Jasinski DR; O'Grady KE; Chisholm CA; Choo RE; Crocetti M; Dudas R; Harrow C; Huestis MA; Jansson LM; Lantz M; Lester BM; Milio L
    Drug Alcohol Depend; 2005 Jul; 79(1):1-10. PubMed ID: 15943939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of neonates conceived on methadone maintenance therapy.
    McCarthy JJ; Leamon MH; Stenson G; Biles LA
    J Subst Abuse Treat; 2008 Sep; 35(2):202-6. PubMed ID: 18077124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gender and NAS: does sex matter?
    Holbrook A; Kaltenbach K
    Drug Alcohol Depend; 2010 Nov; 112(1-2):156-9. PubMed ID: 20576365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of methadone dose regimen on neonatal abstinence syndrome.
    McCarthy JJ; Leamon MH; Willits NH; Salo R
    J Addict Med; 2015; 9(2):105-10. PubMed ID: 25599433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perinatal risk factors for the neonatal abstinence syndrome in infants born to women on methadone maintenance therapy.
    Liu AJ; Jones MP; Murray H; Cook CM; Nanan R
    Aust N Z J Obstet Gynaecol; 2010 Jun; 50(3):253-8. PubMed ID: 20618243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternal and neonatal factors impacting response to methadone therapy in infants treated for neonatal abstinence syndrome.
    Isemann B; Meinzen-Derr J; Akinbi H
    J Perinatol; 2011 Jan; 31(1):25-9. PubMed ID: 20508596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methadone maintenance program in pregnancy in a Swiss perinatal center (II): neonatal outcome and social resources.
    Arlettaz R; Kashiwagi M; Das-Kundu S; Fauchère JC; Lang A; Bucher HU
    Acta Obstet Gynecol Scand; 2005 Feb; 84(2):145-50. PubMed ID: 15683374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Outpatient Methadone Weaning Program by a Neonatal Intensive Care Unit for Neonatal Abstinence Syndrome.
    Lai A; Philpot P; Boucher J; Meyer A
    Popul Health Manag; 2017 Oct; 20(5):397-401. PubMed ID: 28430046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a pharmacist-managed methadone taper*.
    Steineck KJ; Skoglund AK; Carlson MK; Gupta S
    Pediatr Crit Care Med; 2014 Mar; 15(3):206-10. PubMed ID: 24448326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.